Publicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (24)

2024

  1. Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3

    Histology and histopathology, Vol. 39, Núm. 1, pp. 35-40

  2. Elevated tissue expression of RANKL and RANK is associated with poorer survival rates in pancreatic cancer patients

    Histology and histopathology, Vol. 39, Núm. 9, pp. 1133-1140

  3. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

    Medicina (Lithuania), Vol. 60, Núm. 1

  4. Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer

    Current Issues in Molecular Biology, Vol. 46, Núm. 5, pp. 3839-3865

  5. Pupil reflex as a marker of activity and prognosis in heart failure: a longitudinal and prospective study

    ESC Heart Failure, Vol. 11, Núm. 4, pp. 1947-1954

2023

  1. An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  2. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer

    Journal of Personalized Medicine, Vol. 13, Núm. 2

2022

  1. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer

    Cancers, Vol. 14, Núm. 8

  2. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

    Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453

  3. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer

    Antioxidants, Vol. 11, Núm. 4

  4. Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma—A Histopathological Study

    Medicina (Lithuania), Vol. 58, Núm. 6

  5. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer

    Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459

  6. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  7. Towards the Search for Potential Biomarkers in Osteosarcoma: State-of-the-Art and Translational Expectations

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  8. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine

    Frontiers in Oncology, Vol. 12

2021

  1. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)

    Oncology Letters, Vol. 22, Núm. 5

2017

  1. Markers of endothelial damage in patients with chronic kidney disease on hemodialysis

    American Journal of Physiology - Renal Physiology, Vol. 312, Núm. 4, pp. F673-F681

  2. Online Hemodiafiltration Reduces Bisphenol A Levels

    Therapeutic Apheresis and Dialysis, Vol. 21, Núm. 1, pp. 96-101

2016

  1. El bisfenol A: un factor ambiental implicado en el daño nefrovascular

    Nefrologia, Vol. 36, Núm. 1, pp. 5-9

2008

  1. 15-Deoxy-delta12,14-prostaglandin-J2 up-regulates cyclooxygenase-2 but inhibits prostaglandin-E2 production through a thiol antioxidant-sensitive mechanism

    Pharmacological Research, Vol. 57, Núm. 5, pp. 344-350